Iovance Biotherapeutics, Inc IOVA

meitshel Premium

This is not a financial advice! I see first a pullback coming, w8 for it and watch PA closely before entering. Most info on the chart. Trade carefully!

Bixley

IOVA formed a large bearish Rising Wedge on this Weekly timeframe This has led to a big downward move, which correlates well with the rising wedge, being a primarily bearish pattern Support has yet to be found on the Weekly timeframe

Bullishcharts Premium

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic...

zrrsys Updated 

Iovance Biotherapeutics is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

S0rt0

Let's start with a weekly chart (not a logarithm). There are 2 relative bullish divergences, we are also not in a bad zone of the horizontal and inclined trend (depends on whether 2019 candles are considered a puncture). Bearish divergence is also present, but perhaps we will win back it. There are also hidden bulls on the monthly. Fibo levels in chart options...

ramkdlr

turnaround volume and short term bullish pattern formed

Edrisahmadyar

Iovance Biotherapeutics aims to improve patient care by making T cell-based immunotherapies broadly accessible for the treatment of patients with solid tumors and blood cancers. Tumor infiltrating lymphocyte (TIL) therapy uses a patient's own immune cells to attack cancer. TIL cells are extracted from a patient's own tumor tissue, expanded through a proprietary...

Southernitup Pro+

Handle nearly complete

MQP Premium Updated 

COMPLETE UPDATE FOR IOVA. Notes: The difference between complete draft and incomplete draft is basically blind spots that show up on different looks. Anyway, under 35 is moderately strong buy for 43-44 late January or early February.

MQP Premium

THE LIGHT GRAY ROUTE IS TECHNICALLY DRAFT 1 EVEN THOUGH I DIDN'T CALL IT THAT. Notes: I started this for a request a while ago, but noticed that its strong bounce after the recent sell off (bad news from FDA or something like that) had real volume structure that is ahead of price. That is to say that this is a strong stock that may catch all sorts of fire after...

tradeedge

exit at 35around 12/20

thetraderP Updated 

was a good buy in the 30-32 range but i still think it's a buy here too, institutional interest, everyone likes it, i think it's headed to 40 within a month no prob unless the market tanks, also think it's good long term hold unless the story changes

MQP Premium Updated 

This is 12-month outlook for IOVA from several different angles (meaning sized bars, heavy emphasis on 1-day and 2-day). Temporary weakness in volume structure has been considered and expected to resolve by January 2021. Future looks bright.

DOW_DAX

IOVA_LONG TP1@34.51 TP2@36.26 ENTRY1@28.81 ENTRY2@27.08 SL@25.79

fullcount Premium

asc triangle-had recent Dec flow

stephanelibatd

Hey traders, IOVANCE BIOTHERAPEUTICS is in a bullish continuation with a large stable buying volume at the end of the session. And she broke the VWAP by force, on the TIMEFRAME 5 Min. It takes off from the same VWAP in the TIMEFRAME 1 Min, we can notice a doji bull candle with a refusal from the buyers. In this situation as at the top of the consolidation zone, it...

Southernitup Pro+

IOVA box on the weekly

Southernitup Pro+

IOVA weekly box